Glycaemic Control in Women With Type 1 Diabetes and Preeclampsia Risk: A Nationwide Cohort Study
BJOG: An International Journal of Obstetrics & Gynaecology · 2026
DOI: 10.1111/1471-0528.18339 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2026. Verfasst von Natalie Holowko und 8 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Pre-Eclampsia, Diabetes Mellitus, Type 1, Glycemic Control, Pregnancy in Diabetics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region Stockholm, Vetenskapsrådet, Forskningsrådet om Hälsa, Arbetsliv och Välfärd.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
No large‐scale studies exist investigating glycaemic control around conception and preeclampsia risk.
Design
Population‐based nationwide cohort study using the National Diabetes Register and other health registers.
Setting
Sweden. Population Singleton pregnancies between 2003 and 2019 ( N = 1 689 301); 4429 with type 1 diabetes (T1DM) and 1 684 872 without.
Methods
The main exposure was having a pre‐gestational diagnosis of T1DM (first diagnosis anytime ≤ 91 days after conception and ≥ 1value of glycated haemoglobin (HbA1c) within ±90 days from conception). Peri‐conceptional glycaemic control was categorised using the most recent HbA1c measurement (mmol/mol: < 48; 48–61; 62–75; ≥ 76). Unexposed were women without any diabetes diagnosis (≤ 91 days after conception). Main Outcome Measures Preeclampsia was defined using ICD codes and further categorised according to completed gestational weeks at delivery with preeclampsia diagnosis: early preterm preeclampsia (< 34 + 0), late preterm preeclampsia (34 + 0 to 36 + 6), or term preeclampsia (≥ 37 + 0).
Results
16.8% of women with T1DM developed preeclampsia, compared to 2.9% of women without diabetes (adjusted RR [aRR] 4.7, 95% CI 4.4–5.0). Preeclampsia risk increased with peri‐conceptional HbA1c, from 11.6% in women with HbA1c < 48 mmol/mol to 23.3% in women with HbA1c ≥ 76 mmol/mol. Compared to unexposed women, there was a dose–response relationship between HbA1c and preeclampsia in women with T1DM (HbA1c < 48 mmol/mol aRR 3.4 (2.9–4.0); HbA1c 48–61 mmol/mol aRR 4.6 (4.2–5.1); HbA1c 62–75 mmol/mol aRR 5.7 (5.0–6.5): HbA1c ≥ 76 mmol/mol aRR 6.3 (CI 5.3–7.7)). Compared to unexposed women, the aRR of term preeclampsia was 3.5 times higher (3.1–3.9) in women with T1DM, while the aRR was much higher for early preterm preeclampsia (aRR 7.2: 6.1–8.5) and late preterm preeclampsia (aRR 9.9: 8.8–11.1).
Conclusions
Women with T1DM had a higher risk of preeclampsia, which increased in a dose–response manner with poorer peri‐conceptional glycaemic control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
- Division of Obstetrics and Gynaecology, Karolinska University Hospital, Stockholm, Sweden.
- The Ritchie Centre, Hudson Institute of Medical Research, Clayton, Victoria, Australia.
- Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- Department of Public Health Sciences, Thompson School of Social Work & Public Health, University of Hawai'i at Mānoa, Honolulu, HI, USA.
ORCID-Profile: Anna Sandström, Olof Stephansson
Förderung
- Region Stockholm
- Vetenskapsrådet
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- Spädbarnsfonden
Zitieren
APA
Holowko, N., Roos, N., Pasternak, B., Söderling, J., Neovius, M., Gudbjörnsdottir, S., Sandström, A., Ludvigsson, J. F., & Stephansson, O. (2026). Glycaemic Control in Women With Type 1 Diabetes and Preeclampsia Risk: A Nationwide Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.18339
Vancouver
Holowko N, Roos N, Pasternak B, Söderling J, Neovius M, Gudbjörnsdottir S, et al. Glycaemic Control in Women With Type 1 Diabetes and Preeclampsia Risk: A Nationwide Cohort Study. BJOG: An International Journal of Obstetrics & Gynaecology. 2026. doi:10.1111/1471-0528.18339
BibTeX
@article{Holowko2026,
author = {Holowko, Natalie and Roos, Nathalie and Pasternak, Björn and Söderling, Jonas and Neovius, Martin and Gudbjörnsdottir, Soffia and Sandström, Anna and Ludvigsson, Jonas F and Stephansson, Olof},
title = {Glycaemic Control in Women With Type 1 Diabetes and Preeclampsia Risk: A Nationwide Cohort Study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2026},
doi = {10.1111/1471-0528.18339}
}
EUVIMED